A Phase ⅠStudy of the Human Body Tolerance Research of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried
Phase of Trial: Phase I
Latest Information Update: 04 Jun 2018
At a glance
- Drugs Mycobacterium riyadhense (Primary)
- Indications Tuberculosis
- Focus Adverse reactions
- Sponsors AnHui Longcom Biologic Pharmacy
- 31 May 2018 Status changed from not yet recruiting to recruiting.
- 10 Apr 2018 Planned number of patients changed from 175 to 135.
- 10 Apr 2018 Planned End Date changed from 1 Dec 2018 to 1 Aug 2019.